Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LifeTech Scientific's Total Liabilities for the quarter that ended in Dec. 2025 was HK$1,698 Mil.
LifeTech Scientific's quarterly Total Liabilities
increased
from Dec. 2024 (HK$1,521.38 Mil) to Jun. 2025 (HK$1,745.33 Mil) but then
declined
from Jun. 2025 (HK$1,745.33 Mil) to Dec. 2025 (HK$1,698.32 Mil).
LifeTech Scientific's annual Total Liabilities
increased
from Dec. 2023 (HK$1,501.10 Mil) to Dec. 2024 (HK$1,521.38 Mil) and
increased
from Dec. 2024 (HK$1,521.38 Mil) to Dec. 2025 (HK$1,698.32 Mil).
LifeTech Scientific Total Liabilities Related Terms
LifeTech Scientific Total Liabilities Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
LifeTech Scientific's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of HK$1,698 Mil mean?
LifeTech Scientific (HKSE:01302) has a Total Liabilities of HK$1,698 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for LifeTech Scientific and its competitors.
Is LifeTech Scientific's Total Liabilities too high?
LifeTech Scientific's current Total Liabilities is HK$1,698 Mil. Overall, LifeTech Scientific has a GF Score™ of 95/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's Total Liabilities compare to ABT and SYK?
LifeTech Scientific's Total Liabilities of HK$1,698 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for LifeTech Scientific and its competitors. LifeTech Scientific's current Total Liabilities is HK$1,698 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
Based on GuruFocus' analysis, LifeTech Scientific (HKSE:01302) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.12, compared to a current price of HK$1.39 — trading 34.4% below its estimated fair value. The current Total Liabilities is HK$1,698 Mil. LifeTech Scientific's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For LifeTech Scientific (HKSE:01302), the current Total Liabilities is HK$1,698 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (HKSE:01302) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of HK$1.39 is trading 34.4% below its estimated GF Value™ of HK$2.12.
GuruFocus considers LifeTech Scientific to be Possible Value Trap.
Key valuation signals for HKSE:01302:
Total Liabilities: HK$1,698 Mil
GF Value™: HK$2.12 vs. price of HK$1.39 (34.4% below fair value)
No single metric tells the full story. See the HKSE:01302 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
95GF Score
Get the complete analysis for HKSE:01302
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01302 has been successfully added to your 
